Company Name: |
S.Z. PhyStandard Bio-Tech. Co., Ltd.
|
Tel: |
0755-4000505016 13380397412 |
Email: |
3001272453@qq.com |
Products Intro: |
Product Name:Gefitinib-d6 CAS:1228664-49-0 Purity:99% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Nanjing XiZe Biotechnology CO., Ltd.
|
Tel: |
025-58362220 15250997978 |
Email: |
1511893459@qq.com |
Products Intro: |
Product Name:Gefitinib-d6 CAS:1228664-49-0 Purity:95% HPLC Package:10mg;25mg;50mg;100mg;250mg;500mg;1g
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:Gefitinib-d6 CAS:1228664-49-0 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
Company Name: |
Cato Research Chemicals Inc.
|
Tel: |
020-81215950 4000-868-328 |
Email: |
customer@uwalab.com |
Products Intro: |
Product Name:Gefitinib-d6 CAS:1228664-49-0 Purity:95%(HPLC) Package:10mg;25mg;50mg;100mg
|
|
| Gefitinib-d6 Basic information |
Product Name: | Gefitinib-d6 | Synonyms: | Gefitinib-d6;Hexadeuterated gefitinib;[2H6]-Gefitinib;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy-1,1,2,2,3,3-d6]-4-quinazolinamine | CAS: | 1228664-49-0 | MF: | C22H24ClFN4O3 | MW: | 446.91 | EINECS: | | Product Categories: | | Mol File: | 1228664-49-0.mol | ![Gefitinib-d6 Structure](CAS/20181012/GIF/1228664-49-0.gif) |
| Gefitinib-d6 Chemical Properties |
storage temp. | Store at -20°C | solubility | DMF: 20 mg/ml,DMSO: 20 mg/ml,DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml,Ethanol: 0.3 mg/ml | form | A solid | color | White to off-white |
| Gefitinib-d6 Usage And Synthesis |
Description | Gefitinib-d6 is intended for use as an internal standard for the quantification of gefitinib by GC- or LC-MS. Gefitinib is an EGFR inhibitor (IC50s = 0.023-0.079 μM). It inhibits colony formation of GEO colon, ZR-75-1 and MCF-10A breast, and OVCAR-3 ovarian cancer cell lines in soft agar assays (IC50s = 0.2-0.4 μM). Gefitinib (0.1 to 1 μM) induces apoptosis and inhibits EGFR autophosphorylation in the same cells. In vivo, gefitinib (1.25, 2.5, and 5 mg/kg) reduces tumor volume and increases survival in a GEO mouse xenograft model. Formulations containing gefitinib have been used in the treatment of non-small cell lung cancer (NSCLC). | Uses | Gefitinib-d6 is the labeled version of Gefitinib (G304000), which is an antineoplastic. |
| Gefitinib-d6 Preparation Products And Raw materials |
|